AQUIS STOCK EXCHANGE

In 2025, heart health products developer ProBiotix Health (PBX) increased revenues by 45% to £2.73m. The loss was reduced from £852,000 to £1.24m. Revenues continue to grow in the first quarter of the new financial year, and it has achieved profitability. Cash was £1.27m at the end of 2025. The order book has more than doubled to £1.3m. The company is diversifying into new medical areas.

Dermatology products developer Incanthera (INC) says direct to consumer sales of Skin + CELL products have been disappointing, generating £12,400. Discussions continue relating to retail distribution. No bulk sale will be achieved before the end of the March 2026 financial year, so stocks will be higher than anticipated. There are also technology licensing talks. The company has to be careful with working capital, but it believes it has enough cash for immediate requirements.

Oscillate (SRVL), which is changing its name to Serval Resources, is acquiring Kalahari Copper and moving to AIM on 27 April. The strategy is to build a business with a range of copper exploration and development assets. There will be a 50-for-one share consolidation. There will be a share issue to raise £2.9m at 22.5p/share. A WRAP retail offer could raise up to $300,000.

Mendell Helium (MDH) expects to publish the document for the move to AIM during April. That will spark the exercise of the option to acquire M3 Helium. The Rost 2-26 well has reached 4,540 feet. This will test helium prospects. There are preparations for the re-completion of Schneweis Ventures 13A well.

Valereum (VLRM) confirms the exclusivity agreement with Quantum Global Photonics and the definitive agreement is expected by the end of April. As part of the agreement, the first coupon payment for medium term notes of $3.9m will be a combination of cash and VGOLD-CORE (independently valued and verified) gold-backed tokens, where the launch is subject to regulatory approval. The deal involves technology integration, tokenisation and profit sharing. So far, $900,000 has been drawn down from the $2.5m investment from Blubird Global Inc. There are currently talks with Blubird Global about revising the terms of the funding, which could mean that funding could end.

Zak Mir is no longer chief executive of Lift Global Ventures (LFT) and he is not running the investor relations business Miriad any longer. The investment strategy has changed to an AI focus. Cash was £199,000 at the end of 2025 and subsequently a £40,000 settlement was agreed with a former consultant.

Heart medicines developer Cardiogeni (CGNI) says that the share swap deal with Kira Health Invest AG is progressing and could complete by 10 April. Kira Health Invest AG will acquire 67.5% of subsidiary Cell Therapy in return for a 32.5% shareholding in Kira’s hotels and wellness clinics subsidiary Lumen Clinics, which has assets of more than €100m.

Time to ACT (TTA) has appointed VSA Capital as corporate adviser and has raised £415,000 at 6p/share. The company is in talks to acquire the assets of heat treatment business MTE Heat Treatment, which is in administration. This will fit with Diffusion Alloys. It is not buying any asset from Versarien. There are other potential acquisitions.

Investment company Gledhow Investments (GDH) had NAV of £1.2m at the end of September 2025. Net cash is currently £762,000 following recent disposals. This provides the opportunity to take advantage of market volatility.

IntelliAM AI (INT) has bought the business and assets of RBM Lubrications for £25,000 payable in cash at the end of 2029. This expands the business in Scotland.

Oberon Investments (OBE) has launched a global thematic equity fund called TM Oberon Theseus Fund. It will be structured around five to eight core themes and have up to 75 investments.

B HODL (HODL) has completed the initial At-The-Market equity offer and raised £42,300 at 7.05p/share. Another Bitcoin has been acquired for £51,234. The total holding is 165.487 Bitcoin which cost an average of £81,962 each.

Digital asset miner Sterling Digital (ASIC) did not have any revenues in the period to December 2025. There was £3.67m in the bank after the Aquis flotation. Data mining equipment has been acquired, and Bitcoin should be being produced by the end of the second quarter of 2026.

South west England focused minerals explorer Tamar Minerals (TMR) had £171,000 in cash at the end of 2025 following a £256,000 cash outflow from operations in the previous six months. Since, then £2.04m has been raised.

Fund of funds investment company SuperSeed Capital (WWW) made realised and unrealised gains of more than £452,000 in 2025. This increased NAV from 1.2544p/share to 1.3668p/share.

Mollyroe (MOY) has raised £470,000 through a convertible loan note issue and £155,000 at 0.25p/share, which is also the conversion price for the loan notes. The loan facility to AI film maker Cascade has been increased from £300,000 to £500,000. Mollyroe will receive and arrangement fee of £40,000.

Macaulay Capital (MCAP) has raised £225,000 from the exercise of warrants at 25p each.

BWA Group (BWAP) managing director James Butterfield bought 1.4 million shares at 0.29p each and owns 8.02% of the company.

JP JENKINS

Surrey-based Oomisoft (OOMI) joined JP Jenkins on 1 April. The company provides membership management software, CRM and digital services. The customer is not for profit and professional organisations.

ASSET MATCH

Anti-microbial technology developer Byotrol (BYOT) has raised £250,000 at 016p/share. The cash will help to fund growth opportunities.

Recruitment services provider Macdonald and Company (MAC1) is asking for shareholder approval for a share buyback from William Buck and Robin Glover. This relates to a restructuring of interests in Asia. The general meeting is 16 April.

AIM

Building products supplier BRCK (BRCK) has received an unsolicited bid approach from Atlas Holdings LLC and after initial contact and exchange of information a 65p/share indicative offer was made. The share price has not been that level since June 2025. That offer was rejected by the board on 23 March. Atlas will be provided with additional information to see whether it can come up with a better offer, but it says this would not be enough for a firm bid.

CleanTech Lithium (CTL) has published the pre-feasibility study for the Laguna Verde lithium brine project in Chile. This shows a NPV10 of $699m over a 25-year period. This assumes extracting 15,000t per year of battery-grade lithium carbonate. The operating cost is assumed to be $5,768/t and a sale price of $22,500/t. Upfront capex is $748m. First production would be 2031.

Steel structures supplier Billington (BILN) has gained new contracts worth £50m even though the market is still relatively weak. This helps to underpin expectations for 2026, although some of the work will be done in 2027. The 2025 results are due to be published later this month. A pre-tax profit of £3.5m is forecast before a recovery to £8.3m. Manufacturing has been streamlined and Cavendish may reassess forecasts when the results are published.

Whisky supplier Artisanal Spirits Company (ART) was hit by tariffs and the US government shutdown. Elsewhere, there was an improvement in revenues last year. However, overall revenues dipped from £23.6m to £19.9m and that meant that the loss was raised from £3.1m to £7m. Net debt was £31.5m and this should start to reduce this year. The company has changed its way of trading with the US and taken on the distribution in the country.

There was a return to growth at CML Microsystems (CML) in the second half. However, the company will still make a full year loss, rather than the small profit previously expected, because the growth was in lower margin revenues. Supply chain problems have eased. Shore says it will publish 2026-27 forecasts after the latest results are published on 16 June.

Mobile games developer Gaming Realms (GMR) has been hit by changes to stake limits in the UK and there will be another setback when the tax rate increases this year. Revenues improved from £28.5m to £31.4m, while pre-tax profit rose from £8.3m to £9m as management adapted to the stake changes and kept control of costs. More games and adding licence partners have helped revenues continue to rise. North American revenues continue to grow.

Wound healing technology developer AOTI Inc (AOTI) says 2025 revenues were $66.5m, up 15% on 2024. Underlying pre-tax profit was $3.1m, compared with a loss last year. Net debt reached $6.5m. There is a $1.7m provision on money owed by Arizona. Revenues could still rise this year even though AOTI is pulling out of Arizona due to difficulty in getting paid, but profit could decline to $1.2m before starting to grow again. Outstanding debt from Arizona may eventually be reclaimed. A CMS local coverage determination is still expected in the near-term and that will provide some positivity.

Greatland Resources (GGP) benefited from a recovery in the gold price to $4,677.28/ounce. Earlier in the week, it revealed a mineral resource estimate for the O’Callaghans tungsten copper zinc lead deposit. There is 70Mt @ 0.35% of tungsten trioxide. The Telfer mineral resource estimate has been raised by 150% to 8 million ounces. Together with Havieron, the resources could be mined for many decades.

Abingdon Health (ABDX) has won a series of contracts worth £4.8m with a US client. This covers the development of multiplex quantitative lateral flow assay systems for human testing which will be delivered over 27 months. This supports the decision to expand capacity in the US. There could be a subsequent manufacturing contract. The company is set to move to around breakeven in 2026-27. The share price gained 10.3% to 8p.

Ariana Resources (AAU) reported a £12.4m loss for 2025, but this is almost all down to the change in valuation of the Turkey joint venture. That is a non-cash adjustment. The cash outflow from operating activities was £2.6m. Progress is being made with the Dokwe project in Zimbabwe and there is £5.4m in the bank to fund its development.

Monoclonal antibodies developer Bioventix (BVXP) reported interim revenues 9% lower at £6.2m. China was a tough market and some products are maturing. Pre-tax profit was slightly lower at £4.9m. Cash was £5.1m at the end of 2025. The customer base is being broadened and there is longer-term potential for royalties from the company’s antibodies that are included in products. Full year pre-tax profit is set to fall from £10.2m to £9.6m. The full year dividend is set to be unchanged at 150p/share even though it is not going to be covered by earnings.

Digital finance hub Tap Global Group (TAP) interim revenues fell from £1.8m to £1.7m. There was also £210,000 of income from settlement with crypto currency exchange Bitfinex. Cash was £433,000 at the end of 2025.

In-game advertising technology developer Mirriad Advertising (MIRI) says that the expected upturn in February and March did not happen because of the Middle East conflict. It did sign a services agreement with a UK media conglomerate. There is £675,000 in the bank, but more cash will be required before the 2025 accounts are published.

Wellheads and connectors Plexus Holdings (POS) reported a reduction in interim revenues from £2.9m to £1.2m because of delays in projects, particularly in the North Sea due to tax uncertainty and inability to offset decommissioning costs. Activity is likely to remain subdued in the second half with the assumption that work will recover in 2026-27. A full year loss is forecast before a return to profit in 2026-27. The estate of William Black has built up a stake of 5%.

MAIN MARKET

Construction equipment hire company Speedy Hire (SDY) has not made the expected progress in the second half. Contract delays hampered revenues. The latest trading statement has led to a reduction in forecast earnings for 2025-26 and 2026-27. A loss of £1.5m is estimated for the year to March 2026. Net debt is expected to be £159m. The dividend is set to be slashed to 1p/share.

Solvonis Therapeutics (SVNS) has been granted a US patent for a “monoamine modulator compound series from its post-traumatic stress disorder (PTSD)” programme. This market covers more than 20 million people in the US and major European markets. This programme is part of a broader platform. SVN-114 is the lead candidate.

Digital assets investor KR1 (KR1) generated technology infrastructure income of £106,000 from staking activities and that takes the total for 2026 so far to £283,000. Financial income of £2,350 during February. NAV is 21.3p/share, down from 23.8p/share at the end of January 2026.

Andrew Hore